Results 91 to 100 of about 178,855,135 (215)

Bisphosphonate-related osteonecrosis of the jaw: current state of the problem

, 2017
The article presents review of the literature on the current state of the problem of bisphosphonate-related osteonecrosis of the jaw. In Russia and abroad there are numerous reports of atypical lesions of the maxilla associated with taking medications on
E M Spevak, A N Tsymbal
core   +1 more source

Chinese Guideline on Risk Management of Osteoporosis in the General Public

Orthopaedic Surgery, Volume 18, Issue 10, Page 2015-2031, October 2026.
Summary of the background, key recommendations, and expected impact of the public guideline for osteoporosis risk management. ABSTRACT Background Osteoporosis is a common chronic skeletal disorder characterized by decreased bone mass and microarchitectural deterioration, resulting in increased fragility and fracture risk. With rapid population aging in
Shiyong Zhang, Jinqiu Yuan, Zhuojing Luo, Jiacan Su, Weibo Xia, Kehu Yang, Fuxin Wei, Osteoporosis Group, Chinese Association of Orthopaedic Surgeons, Youth Osteoporosis Group, Chinese Orthopaedic Association, Chinese Medical Association, Health Communication Branch, Chinese Preventive Medicine Association, Spine and Joint Health Branch, Guangdong Health Care Association, Chinese Health Risk Management Collaboration–Osteoporosis Group (CHRIMAC‐OP), Zhuojing Luo, Jiacan Su, Weibo Xia, Kehu Yang, Fuxin Wei, Jinqiu Yuan, Xiao Chen, Bo Gao, Yang Guo, Xiaofeng Gong, Junjie Huang, Yafang Huang, Tianyong Hou, Da He, Bin Liu, Yajun Liu, Fangping Li, Ying Li, Wei Li, Jiang Li, Zhihao Li, Xiahong Lin, Houqing Long, Jianwen Mo, Wenfei Ni, Yuanjun Teng, Liang Wang, Xiaobin Wang, Hongli Wang, Nan Wu, Hongfei Xiang, Bin Yan, Dejin Yang, Min Yang, Wei Ye, Hongping Yu, Ziji Zhang, Shiyong Zhang, Xinyu Chen, Ningning Chen, Qiangsheng He, Linmin Hu, Wenjing Li, Zijun Li, Qiji Li, Chengkai Lin, Qingfeng Luo, Tianyi Liu, Ningning Mi, Mina Ma, Jun Shen, Peng She, Huidong Tian, Siqing Wu, Junming Wan, Yongsheng Wang, Bin Xia, Peng Xie, Jinyu Zhao, Fei Zhang, Penghui Zhang, Danni Wang, Lei Cheng, Zhongshi Li, Xinyu Liu, Jing Wang, Shengping Yang, Binsheng Yu   +84 more
wiley   +1 more source

RANK-Ligand inhibitor associated osteonecrosis of the jaw

, 2013
Osteonecrosis of the jaw may be caused by many different triggers. One of them is described to be the drug or medication related osteonecrosis of the jaw. Since many years bisphosphonates induced the dreaded diagnosis.
Smeets, Ralf, Rashad, A, Smeets, R, Heiland, M, Heiland, Max, Rashad, Ashkan   +5 more
core   +1 more source

Risk factors for bisphosphonate-associated osteonecrosis of the jaw in the prospective randomized trial of adjuvant bisphosphonates for early-stage breast cancer (SWOG 0307). [PDF]

Support Care Cancer, 2021
Kizub DA, Miao J, Schubert MM, Paterson AHG, Clemons M, Dees EC, Ingle JN, Falkson CI, Barlow WE, Hortobagyi GN, Gralow JR.   +10 more
europepmc   +1 more source

Osteonecrosis of the jaw in association to bisphosphonates [PDF]

, 2008
Thesis (M.A.)--Boston University, 2008.The use of bisphosphonate has become more widespread for the treatment of bone metastasis, multiple myeloma, osteoporosis, Paget's disease and other bone malignancies.
Mattos, Ana Carolina Lopes
core   +1 more source

Relationship Between Osteonecrosis of the Jaw and Bisphosphonate Treatment [PDF]

, 2010
Terapija bisfosfonatima i njezina etiopatogenetska povezanost s aseptičkom osteonekrozom čeljusti važan je javnozdravstveni problem današnjice.
Ladislav Krapac, Ivana Pavičin, Ivana Savić Pavičin, Keros, Jadranka, Krapac, Ladislav, Badel, Tomislav, Savić Pavičin, Ivana, Jadranka Keros, Tomislav Badel   +8 more
core   +1 more source

Bisphosphonate-associated osteonecrosis of the jaw in patients with multiple myeloma

, 2009
Bisphosphonate-associated osteonecrosis of the jaw (BON) is mainly observed in patients with multiple myeloma, and to a lesser extent in breast and prostate cancer patients receiving intravenous treatment with potent bisphosphonates. The incidence of BON
Abildgaard, Niels, Marker, Peter, Vangsted, Annette, Lund, Thomas, Gregersen, Henrik   +4 more
core   +3 more sources

Endodontic therapy and Medication-related osteonecrosis of the jaw onset: a scoping review and expert opinion-based qualitative meta-synthesis

BMC Oral Health
Introduction Medication-related osteonecrosis of the Jaw (MRONJ) is a serious side effect of bone-modifying agents (BMAs), including bisphosphonates, denosumab, and antiangiogenic drugs.
R. Mauceri, M. Coppini, V. C. A. Caponio, F. Zamparini, C. Prati, G. Campisi   +5 more
doaj   +1 more source

A retrospective case series on bisphosphonate related osteonecrosis of the jaw in 20 cats

Frontiers in Veterinary Science
IntroductionThis retrospective study highlights the salient aspects of a series of feline patients affected with bisphosphonate related osteonecrosis of the jaw. Though more commonly published in human literature, this presentation is rare in cats.
Suzanna L. Hatunen, Jamie G. Anderson, Cynthia M. Bell, Hugo C. Campos, Matthew D. Finkelman, Bonnie H. Shope   +5 more
doaj   +1 more source

Re-appraisal of dental clearance protocol before anti-resorptive agents for osteoporosis using the modified Delphi technique

BMC Oral Health
Background Patients undergoing anti-resorptive agent (ARA) therapy are at risk of medication-related osteonecrosis of the jaw (MRONJ). Although existing guidelines encourage dental clearance prior to the initiation of ARA therapy, details on risk ...
Sarah Kho Xian Chua, Ruth Wei Choe, Catherine Hsu Ling Hong, Chee Weng Yong, Chien Joo Sim, Chong Meng Tay, Gabriel Keng Yan Lee, Jacinta Xiaotong Lu, Jing Li Lum, Joanne Ngo Uy, Mei Na Tan, Ren Jie Jacob Chew, Wataru Ode, Wendy Chia-Wei Wang   +13 more
doaj   +1 more source